Vasectomies are on the rise, but not all men are ready to commit to a permanent form of birth control. While the surgery can sometimes be reversed, it’s expensive and doesn’t always work. What if there was another option?
Virginia-based biotech company Contraline is testing a new type of male contraceptive akin to a vasectomy but made to be fully reversible. Today, the company announced that surgeons in Australia have safely performed the procedure on 23 men in an early-stage trial.
The approach uses a soft, water-based substance called a hydrogel that’s injected into the vas deferens—the pair of tubes in the male reproductive tract that transport mature sperm. Within 30
→ Continue reading at Wired - Science